🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This inpatient study enrolls healthy individuals who have opioid use disord...
Status
Not Yet Recruiting
Location
University of Kentucky
Start Date
2026-10-01
Trial ID
NCT07661446
Treatments Being Tested
The purpose of this research is to determine if scheduled intranasal ketami...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05671913
This study aims to compare the pharmacokinetics of naloxone when administer...
Status
Unknown
Location
International Pharmaceutical Research Center (IPRC)
Start Date
2012-06
Trial ID
NCT01622504
Treatments Being Tested
This is a pilot feasibility study assessing the tolerability of chronic adm...
Status
Completed
Location
San Francisco General Hospital Opiate Treatment Outpatient Program
Start Date
2014-07
Trial ID
NCT02028533
This trial studies the attitudes and beliefs of high risk patients and care...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-18
Trial ID
NCT04129138
Treatments Being Tested
Although stress has long been linked to substance use, craving and relapse,...
Status
Completed
Location
Brown University
Start Date
2020-01-06
Trial ID
NCT04051619
Treatments Being Tested
This was a single-dose, randomized, double-blind, placebo-controlled, 3 way...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01595867
Treatments Being Tested
Intranasal (IN) naloxone is available as 2 mg or 4 mg dose with the indicat...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2021-03-01
Trial ID
NCT04764630
Opioid use disorders (OUD) are the second most common type of drug use diso...
Status
Unknown
Location
National Development and Research Institutes, Inc.
Start Date
2017-09-15
Trial ID
NCT03610672
Treatments Being Tested